Serum sample extraction and derivatization for GC-MS and GC-FID analysis
were dried under vacuum at 4 °C and parallel extractions performed on empty microcentrifuge 1 3 7 tubes only served as extraction blanks to account for background (extraction conditions, 1 3 8 derivatization reagents) noise and other sources of contamination (septa, liner, column, vials, 1 3 9 handling among others). Blanks were intermittently used to see that no carryovers occurred 1 4 0 during randomized run orders and to manually filter out contaminating chemicals from the 1 4 1 combined list of features obtained from the blanks. Samples were then sequentially derivatized 1 4 2 with methoxyamine hydrochloride (MeOX) and 1% TMCS in N-methyl-N-trimethylsilyl-1 4 3 trifluoroacetamide (MSTFA) as described elsewhere (7, 18, 19) . Steps involved addition of 10 (Thermo Fisher Scientific™, Austin, TX). Helium carrier gas at a flow rate of 1.6 mL/min was µm film thickness) column. The initial oven temperature was held at 90 °C for 0.5 min, followed 1 5 5 by an initial gradient of 10 °C/min ramp rate to 250 °C, where it was held for 5 min, and a 1 5 6 gradient of 5 °C/min ramp rate to 295 °C. The final temperature was 295 °C and was held for 35 1 5 7 min. Eluting peaks were transferred through an auxiliary transfer temperature of 250 °C into a Q 1 5 8
Exactive™-GC mass spectrometer (Thermo Fisher Scientific™, Bremen, Germany). The mass 1 5 9 spectrometer has a resolving power (RP) of 120,000 full width at half maximum (FWHM) at m/z 1 6 0 200 with EI or CI capabilities. From the ion source, an AQT quadrupole is used for precursor ion 1 6 1 isolation, which leads into the Orbitrap mass analyzer. Electron ionisation (EI) at 70 eV energy, 1 6 2 emission current of 50 µA with an ion source temperature of 230 °C was used in all experiments. and column temperature, the injection temperature, splitless injection conditions, carrier gas and 1 7 3 the linear velocity were the same as those of GC-MS analysis. For both analyses, the acquisition sequence started with blank solvent (pyridine) injections, halogen-derivatives, phthalate, acrylate, and silyloxy, borane, dioxolan, and silan, silox, -1 9 5 derivative compounds were removed from the list manually. For the MS platform, metabolite 1 9 6 annotation and assignment followed the metabolomics standards initiative (MSI) guidelines for 1 9 7 metabolite identification (23), with Level 2 identification based on spectral database match 1 9 8 (match factor >80%) and Level 3 identification where only compound groups were known 1 9 9
(specific ions and RT regions of metabolites). The raw datasets and the metadata obtained from both the platforms are deposited at the normalized, and the color scale represents +2 (high) to -2 (low) abundance in the heat map. DeviumWeb (25) where the output displayed score plots to visualize the sample groups. The data 2 1 8
were scaled with unit variance without any transformation. We previously reported on the analysis of non-human primate serum from a baboon using HR-
GC-MS alone (7). Here, we expanded our metabolomics analysis to human serum, and compared 2 3 1 two orthogonal detection techniques attached to a GC, a MS and a FID detector. Quantitation 2 3 2 using a FID is simple, as FID is a mass-sensitive detector that provides a nearly equal molar and total ion chromatogram (TIC) from MS analysis are provided (Figure 1) . The extracted FID 2 3 6 data (filtered) ( Supplementary Table S1 ) and the annotated MS-data (Supplementary Table   2 3 7 9 S2) are provided. Furthermore, given that there was a solvent delay time used for MS detector, 2 3 8 only peaks from 8 to 60 min. (i.e., total 52 min.) were considered for FID peak quantification as 2 3 9
well, to only compare peaks/metabolites in affixed retention time windows. We ran five compounds/ peaks with < 30% RSD, we retained 298 metabolites in the MS analysis and 83 such 2 5 0 peaks in the FID analysis. A previous study using fatty acid methyl ester (FAME) analysis 2 5 1
showed that 28 FAME standards tested provided similar results for the novel GC-EI-MS-SIM 2 5 2 method and GC-EI-MS in the full scan mode, both of which were slightly worse than GC-FID 2 5 3 analysis (29).
5 4
When we performed hierarchical clustering (HCA) analysis of the top 50 features (either peaks 2 5 5 from FID or metabolites abundances from MS) from the two platforms, the results reveal a 2 5 6 clearer separation of sample groups (blanks vs samples) for the FID analysis (Figure 2 A, B) 2 5 7 when compared to those obtained from MS analysis. Similarly, a metabolite-metabolite Pearson 2 5 8 correlation analysis for peak and metabolite abundances revealed clearer clusters (two such 2 5 9
